Benzene polycarboxylic acids complex with cis-diammineplatinum(II)
Showing 1 - 25 of >10,000
Metastatic Breast Cancer, Stage IV Breast Cancer Trial in Ramat-Gan, Lampang (BP-C1)
Completed
- Metastatic Breast Cancer
- Stage IV Breast Cancer
-
Ramat-Gan, Israel
- +1 more
Oct 3, 2019
Metastatic Breast Cancer, Stage IV Breast Cancer Trial in Thailand (BP-C1, Placebo)
Completed
- Metastatic Breast Cancer
- Stage IV Breast Cancer
- BP-C1
- Placebo
-
Udon Thani, Udon Thani Province, Thailand
- +3 more
Oct 3, 2019
Metastatic Breast Cancer, Stage IV Breast Cancer Trial in Russian Federation, Thailand (BP-C1, Placebo)
Completed
- Metastatic Breast Cancer
- Stage IV Breast Cancer
- BP-C1
- Placebo
-
Moscow, Russian Federation
- +5 more
Oct 8, 2019
Metastatic Breast Cancer, Stage IV Breast Cancer Trial in Russian Federation, Thailand (BP-C1)
Completed
- Metastatic Breast Cancer
- Stage IV Breast Cancer
-
Moscow, Russian Federation
- +6 more
Oct 8, 2019
Acute Lymphoblastic Leukemia, Hyperbilirubinemia Trial in Houston (Levocarnitine, Vitamin B Complex)
Recruiting
- Acute Lymphoblastic Leukemia
- Hyperbilirubinemia
- Levocarnitine
- Vitamin B Complex
-
Houston, TexasM D Anderson Cancer Center
Nov 7, 2022
Remimazolam Benzenesulfonate on Nenhanced Recovery After Surgery, Possible Molecular Mechanism of Remimazolam Benzenesulfonate
Recruiting
- Remimazolam Benzenesulfonate on Nenhanced Recovery After Surgery
- Possible Molecular Mechanism of Remimazolam Benzenesulfonate
- Remimazolam Benzenesulfonate
-
Shaoxing, Zhejiang, ChinaShaoxing People's Hospital
Sep 26, 2022
HER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract Cancer Trial in Seoul
Not yet recruiting
- HER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract Cancer
-
Seoul, Korea, Republic ofSeverance Hospital, Yonsei University Health System
Feb 19, 2023
Non-muscle Invasive Bladder Cancer Trial (TARA-002)
Not yet recruiting
- Non-muscle Invasive Bladder Cancer
- TARA-002
- (no location specified)
Jul 14, 2023
HIV Prevention, Primary Care, PrEP Trial (Patient Level, Multilevel, Control)
Recruiting
- HIV Prevention
- +2 more
- Patient Level
- +2 more
-
Baltimore, MarylandJohns Hopkins Health System
Oct 14, 2022
NSCLC Metastatic Trial (Atezolizumab, Nab paclitaxel, Carboplatin)
Not yet recruiting
- Non-Small Cell Lung Cancer Metastatic
- Atezolizumab
- +5 more
- (no location specified)
Jan 18, 2023
Non-muscle Invasive Bladder Cancer Trial in Hanover, Mount Laurel, Rochester (TARA-002)
Recruiting
- Non-muscle Invasive Bladder Cancer
- TARA-002
-
Los Angeles, California
- +11 more
Jan 31, 2023
Retinitis Pigmentosa Trial in Tel Hashomer (Alga Dunaliella Bardawil, Placebo (starch))
Active, not recruiting
- Retinitis Pigmentosa
- Alga Dunaliella Bardawil
- Placebo (starch)
-
Tel Hashomer, IsraelSheba Medical Center
Jan 15, 2023
Unresectable Intrahepatic Cholangiocarcinoma Trial (Camrelizumab, Gemcitabine Injection, Cisplatin injection)
Not yet recruiting
- Unresectable Intrahepatic Cholangiocarcinoma
- Camrelizumab
- +4 more
- (no location specified)
Feb 17, 2023
Healthy Trial in Worldwide (Ad26.Mos4.HIV, Clade C and Mosaic gp140 HIV bivalent vaccine, Placebo)
Active, not recruiting
- Healthy
- Ad26.Mos4.HIV
- +2 more
-
Birmingham, Alabama
- +52 more
Jan 17, 2023
Stroke, Intracranial Atherosclerotic Stenosis Trial in Beijing (DCB, POBA)
Recruiting
- Stroke
- Intracranial Atherosclerotic Stenosis
- DCB
- POBA
-
Beijing, Beijing, ChinaXuanwu Hospital, Capital Medical University
Sep 19, 2023
Advanced Biliary Tract Cancer Trial in Tianjin (Cadonilimab+Regorafenib+GC)
Not yet recruiting
- Advanced Biliary Tract Cancer
-
Tianjin, Tianjin, ChinaTianjin Cancer Hospital Airport Hospital
Apr 7, 2023
Increasing PrEP Awareness and Demand Among Black Cisgender Women
Not yet recruiting
- HIV
- PrEP
- PrEP awareness materials
- (no location specified)
Jun 8, 2023
Vocal Emotion Communication With Cochlear Implants
Recruiting
- Cochlear Hearing Loss
- Perception of acoustic cues to emotion
- Production of acoustic cues to emotion
-
Tempe, Arizona
- +1 more
Aug 2, 2022
Barrett Esophagus Trial (Obeticholic Acid, Placebo Administration)
Not yet recruiting
- Barrett Esophagus
- Obeticholic Acid
- Placebo Administration
- (no location specified)
Oct 13, 2022
Pancreatic Cancer Trial in Baltimore (Gemcitabine, Cisplatin, Pembrolizumab)
Not yet recruiting
- Pancreatic Cancer
- Gemcitabine
- +2 more
-
Baltimore, MarylandSKCCC Johns Hopkins
Aug 16, 2023
Advanced Cancer Trial in Chengdu, Hangzhou (TQB2223 injection+ Penpulimab Injection)
Recruiting
- Advanced Cancer
- TQB2223 injection+ Penpulimab Injection
-
Chengdu, Sichuan, China
- +1 more
Jun 7, 2023
Multiple Sclerosis Trial in Bordeaux (Clinical assessment, Neuropsychological evaluation, Psychological evaluation)
Recruiting
- Multiple Sclerosis
- Clinical assessment
- +3 more
-
Bordeaux, FranceCHU de Bordeaux - service de neurologie
Jun 15, 2022
Intrahepatic Cholangiocarcinoma Trial in Worldwide (Cisplatin-gemcitabine, Radiation: SIRT + chemo (cisplatin-gemcitabine))
Active, not recruiting
- Intrahepatic Cholangiocarcinoma
- Cisplatin-gemcitabine
- Radiation: SIRT + chemotherapy (cisplatin-gemcitabine)
-
Spokane, Washington
- +22 more
Apr 1, 2022